AI Article Synopsis
- The COVID-19 pandemic, caused by the novel SARS-CoV-2 virus, has posed serious health risks globally since December 2019, with limited treatment options available.
- Convalescent plasma (CP) therapy, an ancient immunotherapeutic method, is proposed as a potentially effective and immediate response to manage the infection.
- While CP therapy has shown positive effects against COVID-19, its long-term use has not been recommended, highlighting the need for further exploration of its application.
Article Abstract
Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of preventive as well as therapeutic options for treating and managing the infection. The use of ancient immunotherapeutic technique - the convalescent plasma (CP) therapy, may act as an immediate and available option to control the COVID-19 pandemic. This review provides a concept and understanding on the CP therapy, its potential to control SARS-CoV-2 pandemic. The CP therapy might act as an immediate saviour for society from the virus. Although the CP therapy has exert affirmative result against COVID-19 it has not been recommended for long time use in COVID-19 and this review gives support for its possible application.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718590 | PMC |
| http://dx.doi.org/10.1016/j.tracli.2020.11.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!